Nano revolution: taking health and medicine to the next level
Insulin is a lifesaving peptide for people with type 1 diabetes and some people with type 2 diabetes. Overly high insulin levels can be dangerous, so insulin is administered using injections or a pump that require tight control. Meet the researcher using nanotech to develop a smart insulin tablet, which would transform how one in ten Australians take their insulin every day.
Join Victoria Cogger to understand how a smart insulin tablet can be a way to manage insulin levels more precisely, eradicate needles and improve the health span of people with diabetes.
Bio
Victoria Cogger was appointed the Director of the ANZAC Research Institute at Concord Hospital in February 2023. The ANZAC is a biomedical research institute focussed on integrating the highest quality innovative research in the basic sciences with clinical and population health.
Victoria leads a multidisciplinary research team focussed on understanding the biology of the liver relating to ageing and disease, and translating this knowledge to develop targeted nanomedicines for the treatment and prevention of these diseases. She is co-founder, scientific adviser and a shareholder of EndoAxiom, a company leading the development of nanomedicines for use in people. Its lead product is oral insulin for the treatment of diabetes – the culmination of 20 years of research collaboration by Victoria and colleagues.
Event
Thursday 3 April, 6:15 – 7:00 PM @The Toxteth, 345 Glebe Point Rd, Glebe NSW 2037
The other talk at this location is There’s no such thing as wastewater – only wasted water at 7:30 – 8:15 PM
Great beer, scrumptious food, and a classic pub feel all with a sprawling outdoor area!
